Axon (AXON) director receives new restricted stock unit grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
GARNREITER MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
AXON ENTERPRISE, INC. director Michael Garnreiter reported equity compensation awards rather than open-market trades. On May 29, 2026, he received two grants of common stock totaling several hundred shares at $0.00 per share as part of his director compensation. A footnote explains these are time-vested restricted stock units granted under Axon’s Amended and Restated 2022 Stock Incentive Plan, scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual Meeting of Shareholders. These transactions reflect routine, plan-based stock awards instead of discretionary buying or selling of Axon shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
GARNREITER MICHAEL
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 611 | $0.00 | -- |
| Grant/Award | Common Stock | 47 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 18,351 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Grant 1 shares: 47 shares
Grant 2 shares: 611 shares
Grant price: $0.00 per share
+1 more
4 metrics
Grant 1 shares
47 shares
Common Stock award on May 29, 2026
Grant 2 shares
611 shares
Common Stock award on May 29, 2026
Grant price
$0.00 per share
Equity compensation, not open-market purchase
Grant date
May 29, 2026
Date of reported stock awards
Key Terms
restricted stock units, Amended and Restated 2022 Stock Incentive Plan, Annual Meeting of Shareholders
3 terms
restricted stock units financial
"Time-vested restricted stock units granted to the reporting person..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated 2022 Stock Incentive Plan financial
"pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan."
FAQ
What did Axon (AXON) director Michael Garnreiter report in this Form 4?
Director Michael Garnreiter reported receiving equity compensation in the form of restricted stock units, not market trades. The filing shows stock awards under Axon’s Amended and Restated 2022 Stock Incentive Plan, granted at no cash cost to him as part of board compensation.
At what price were the Axon (AXON) stock awards granted to the director?
The reported Axon stock awards were granted at $0.00 per share to director Michael Garnreiter. This zero grant price is typical for restricted stock unit awards, which function as equity-based compensation instead of shares bought in the open market.
When do Michael Garnreiter’s Axon (AXON) restricted stock units vest?
The time-vested restricted stock units are scheduled to vest in full on the earlier of the one-year anniversary of the grant date and Axon’s 2027 Annual Meeting of Shareholders. This creates a clear vesting timeline tied to both time and a future shareholder meeting.
Under what plan were the Axon (AXON) director’s stock units granted?
The filing states the restricted stock units were granted under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. This plan governs equity-based compensation awards such as time-vested restricted stock units provided to directors and possibly other participants.